v3.26.1
Consolidated Statements of Stockholders’ Equity (Unaudited) - USD ($)
Common Stock
Additional Paid in Capital
Statutory Reserves
Accumulated Other Comprehensive Loss
Accumulated Deficit
Total
Balance at Dec. 31, 2024 $ 9,161 $ 165,959,857 $ 15,191,645 $ (14,373,199) $ (62,056,383) $ 104,731,081
Balance (in Shares) at Dec. 31, 2024 916,122          
Net loss for the period (2,900,041) (2,900,041)
Conversion of long-term notes into common shares $ 2,044 2,707,492 2,709,536
Conversion of long-term notes into common shares (in Shares) 1,423,058          
Stock compensation expense $ 124 831,396 831,520
Stock compensation expense (in Shares) 12,413          
Offering of the common stock $ 33,003 32,104,828 32,137,831
Offering of the common stock (in Shares) 18,600,285          
Foreign currency translation profit 5,639,664 5,639,664
Balance at Dec. 31, 2025 $ 44,332 201,603,573 15,191,645 (8,733,535) (64,956,424) 143,149,591
Balance (in Shares) at Dec. 31, 2025 20,951,878          
Net loss for the period (547,410) (547,410)
Conversion of long-term notes into common shares $ 2,007 2,546,031 2,548,038
Conversion of long-term notes into common shares (in Shares) 2,007,250          
Stock compensation expense   437,900 437,900
Foreign currency translation profit 2,121,112 2,121,112
Balance at Mar. 31, 2026 $ 46,339 $ 204,587,504 $ 15,191,645 $ (6,612,423) $ (65,503,834) $ 147,709,231
Balance (in Shares) at Mar. 31, 2026 22,959,127